Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology
|
Buy Now
Resistance to Targeted Therapies in Multiple Myeloma (Hardcover, 1st ed. 2021)
Loot Price: R4,033
Discovery Miles 40 330
|
|
Resistance to Targeted Therapies in Multiple Myeloma (Hardcover, 1st ed. 2021)
Series: Resistance to Targeted Anti-Cancer Therapeutics, 22
Expected to ship within 12 - 17 working days
|
Multiple Myeloma remains an incurable malignancy. As the disease
progresses, it invariably becomes resistant to treatment and almost
all patients develop refractory disease. There are multiple
different types of targeted therapies and many of them are used in
combination at different stages of disease. Targeted therapies that
are approved to be used include Proteasome Inhibitors,
Immunomodulatory Drugs and Monoclonal Antibodies. Second and third
generations of these drugs are developed to overcome resistance and
they have unique mechanism of actions. Targeted therapies that are
undergoing clinical trials include CAR-T cells, bi-specific
antibodies, vaccines, ubiquitin ligase inhibitors and BCL-2
inhibitors. This book will help to develop an understanding of
targeted therapies in Multiple Myeloma. Its goal is to provide a
unique review of the mechanism of action and resistance of the many
targeted therapies in Multiple Myeloma by leaders of the field. The
book will be useful for students in medical science, clinicians,
health professionals, scientists, pharmaceutical professionals,
drug developers, and policy makers. This book will provide an
insightful knowledge of the biology of Multiple Myeloma, the
mechanism of action and resistance of targeted therapies,
application of biomarkers and genomics and possible strategies in
overcoming resistance and future development.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.